ASTRAZENECA PHARMA INDIA
Back to Balance Sheet
|
ASTRAZENECA PHARMA INDIA Last 5 Year Total Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹2,377 Cr | ₹1,838 Cr | ₹1,277 Cr | ₹1,142 Cr | ₹977 Cr |
What is the latest Total Liabilities ratio of ASTRAZENECA PHARMA INDIA ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹2,377 Cr |
| Mar2025 | ₹1,838 Cr |
| Mar2024 | ₹1,277 Cr |
| Mar2023 | ₹1,142 Cr |
| Mar2022 | ₹977 Cr |
How is Total Liabilities of ASTRAZENECA PHARMA INDIA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,377 Cr | 29.34 | |
| Mar2025 | ₹1,838 Cr | 43.91 | |
| Mar2024 | ₹1,277 Cr | 11.80 | |
| Mar2023 | ₹1,142 Cr | 16.86 | |
| Mar2022 | ₹977 Cr | - | |
Compare Total Liabilities of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹18,526.3 Cr | -2.9% | -5.9% | -9.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | -2.9% |
-5.9% |
-9.5% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses